top of page
  • overtimeathletics
  • 5 days ago
  • 1 min read

Reston VA | June 3rd, 2025


Dr. Michael Lau brings an impressive background to the Overtime Athletics family. With over a decade of leadership experience in life sciences, molecular diagnostics, and biopharmaceutical development, Dr. Lau currently serves as Chief Executive Officer of Anbio Biotechnology. He also holds the position of Executive Director and Head of Global Business Development at Pharmaron Beijing Co., Ltd. (OTCMKTS: PHBBF), a leading global provider of pharmaceutical R&D services.


Throughout his distinguished career, Dr. Lau has held senior leadership roles at GenScript Biotech, Distek, Boehringer Ingelheim, and Regeneron Pharmaceuticals, where he oversaw major initiatives in biologics manufacturing, GMP operations, and commercialization strategy. In his current roles, he continues to drive business performance, strategic planning, and global growth execution.


Dr. Lau holds a Ph.D. in Biochemistry and Molecular Biology, as well as an Executive MBA. His passion for business development, coupled with a heart for youth sports and community engagement, makes him a fantastic addition to the Overtime Athletics network.

We’re thrilled to have Dr. Lau on board and can’t wait to see the positive impact he’ll bring to families and communities through Overtime Athletics!


 
 

©2025  Overtime Athletics All Rights Reserved

Whelan & Horich LLC

Overtime Franchise LLC

  • Facebook Social Icon
  • Twitter Social Icon
  • Instagram Social Icon

Disclaimer This information is for informational purposes only and is not intended as an offer to sell a franchise. The offer and sale of a franchise can only be made through the delivery and receipt of Overtime Franchise LLC. Franchise Disclosure Documents (FDD). Certain states regulate the offer and sale of franchises. Overtime Franchise LLC. may not be registered in all of those states. If you are a resident of one of those states, we will not offer you a franchise unless and until we have complied with applicable pre-sale registration and disclosure requirements.

bottom of page